Status:

RECRUITING

AI Based Real Time Detection of Endometriosis Lesions

Lead Sponsor:

University Hospital Tuebingen

Conditions:

Endometriosis

Eligibility:

FEMALE

18+ years

Brief Summary

Development of AI-based approaches for automated real-time detection of endometriosis lesions using endoscopic image and video material.

Detailed Description

In the field of endometriosis, artificial intelligence (AI) has been used for diagnoses or even predictions of endometriosis before confirmation through laparoscopy. AI's significant potential in mini...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Written consent after explanation
  • Indication for surgical treatment of endometriosis

Exclusion

  • Expected lack of patient compliance or inability of the patient to understand the purpose of the clinical trial
  • Absence of patient consent
  • Malignancies

Key Trial Info

Start Date :

October 10 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2025

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06873373

Start Date

October 10 2023

End Date

June 30 2025

Last Update

March 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Tuebingen, Department of Women's Health

Tübingen, Germany, 72076